Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

biote Corp

BTMD
Current price
6.57 USD 0 USD (0.00%)
Last closed 6.72 USD
Company
ISIN US0906831039
Sector Healthcare
Industry Medical Care Facilities
Exchange NASDAQ
Capitalization 292 627 808 USD
Yield for 12 month +36.59 %
1Y
3Y
5Y
10Y
15Y
BTMD
21.11.2021 - 28.11.2021

biote Corp. operates in practice-building business within the hormone optimization space. It trains physicians and nurse practitioners in hormone optimization using bioidentical hormone replacement pellet therapy in men and women experiencing hormonal imbalance. The company offers Biote Method, a comprehensive end-to-end practice building platform that provides Biote-certified practitioners with the components developed for practitioners in the hormone optimization space comprising Biote Method education, training, and certification services; practice management software that allows Biote-certified practitioners to order, track, and manage hormone optimization product inventory and other administrative requirements; inventory management software to monitor pellet inventory; and information regarding available hormone replacement therapy products, as well as digital and point-of-care marketing support. It also sells dietary supplements under the Biote brand; and sterile pellet insertion kits that is used with hormone optimization therapies for male and female. The company was founded in 2012 and is headquartered in Irving, Texas. Address: 1875 W. Walnut Hill Ln #100, Irving, TX, United States, 75038

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

9.59 USD

P/E ratio

11.12

Dividend Yield

Current Year

+185 360 000 USD

Last Year

+164 957 000 USD

Current Quarter

+49 169 000 USD

Last Quarter

+46 804 000 USD

Current Year

+124 489 000 USD

Last Year

+110 382 000 USD

Current Quarter

+33 006 000 USD

Last Quarter

+32 687 000 USD

Key Figures BTMD

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA 39 261 000 USD
Operating Margin TTM 16.55 %
PE Ratio 11.12
Return On Assets TTM 20.54 %
PEG Ratio
Return On Equity TTM
Wall Street Target Price 9.59 USD
Revenue TTM 187 232 992 USD
Book Value -4.63 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY -0.2 %
Dividend Yield
Gross Profit TTM 90 579 000 USD
Earnings per share 0.5 USD
Diluted Eps TTM 0.5 USD
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY 341.8 %
Profit Margin 3.67 %

Dividend Analytics BTMD

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History BTMD

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation BTMD

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE 11.12
Forward PE 7.0373
Enterprise Value Revenue 1.4329
Price Sales TTM 1.5629
Enterprise Value EBITDA 8.9157
Price Book MRQ 2.9604

Financials BTMD

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators BTMD

For 52 weeks

3.65 USD 8.44 USD
50 Day MA 5.53 USD
Shares Short Prior Month 951 115
200 Day MA 6 USD
Short Ratio 5.1
Shares Short 881 497
Short Percent 4.15 %